ID   RCPCMi007-A-1
AC   CVCL_A8DK
SY   IPSFF1S deltab2m cl 12; IPSFF1Sdeltab2m cl12
DR   BioSamples; SAMEA8944453
DR   hPSCreg; RCPCMi007-A-1
DR   Wikidata; Q107116727
RX   PubMed=34237591;
CC   From: Federal Research and Clinical Center of Physical-Chemical Medicine; Moscow; Russia.
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 914; B2M.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8DJ ! RCPCMi007-A
SX   Female
AG   45-49Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 5
//
RX   PubMed=34237591; DOI=10.1016/j.scr.2021.102451;
RA   Bogomiakova M.E., Sekretova E.K., Eremeev A.V., Shuvalova L.D.,
RA   Bobrovsky P.A., Zerkalenkova E.A., Lebedeva O.S., Lagarkova M.A.;
RT   "Derivation of induced pluripotent stem cells line (RCPCMi007-A-1)
RT   with inactivation of the beta-2-microglobulin gene by CRISPR/Cas9
RT   genome editing.";
RL   Stem Cell Res. 55:102451-102451(2021).
//